ACN vs CPRX · P/E 24, rev $17.60B vs P/E 18, rev $491.7M
Accenture plc (ACN) versus Catalyst Pharmaceuticals Inc (CPRX) — a side-by-side from cached financials, not a winner call.
Accenture plc (ACN) is a information technology services company listed on US.
Catalyst Pharmaceuticals Inc (CPRX) is a biotechnology company listed on NASDAQ.
Latest reported ACN revenue for 2025-08-31 was $17.60B. Net income was $1.41B. Revenue was down 0.7% from 2025-05-31 to 2025-08-31. ACN currently screens at market cap $186.16B and trailing P/E 23.8.
Latest reported CPRX revenue for 2024-12-31 was $491.7M. Net income was $163.9M. Revenue was up 23.5% from 2023-12-31 to 2024-12-31. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
ACN currently screens at market cap $186.16B and trailing P/E 23.8. CPRX currently screens at market cap $3.84B and trailing P/E 18.2.
Not investment advice. Open the ACN and CPRX stock pages for the full models.
Not investment advice.